H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $20
H.C. Wainwright Sticks to Their Buy Rating for Enanta Pharmaceuticals (ENTA)
H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $20
Analysts Are Bullish on These Healthcare Stocks: TScan Therapeutics (TCRX), Relmada Therapeutics (RLMD)
H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $20
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Orchestra BioMed Holdings (OBIO)
H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $20
Analysts' Top Healthcare Picks: Q32 Bio (QTTB), UnitedHealth (UNH)
J.P. Morgan Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Announces Target Price $19
J.P. Morgan Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Pelthos Therapeutics (PTHS) and Savara (SVRA)
H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $20